Category - Any -Programs & products-Lacutamab-IPH4502-Monalizumab-ANKET-IPH5201-IPH5301Financials and Corporate Year - Any -202620252024202320222021202020192018201720162015201420132012201120102009 Apply Innate Pharma receives a milestone payment for IPH2201, a monoclonal antibody licensed to Novo Nordisk A/S February 28, 2011 Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Current page 8
Innate Pharma receives a milestone payment for IPH2201, a monoclonal antibody licensed to Novo Nordisk A/S February 28, 2011
